Rafferty Asset Management, LLC Novavax Inc Transaction History

Rafferty Asset Management, LLC

$29.4 Billion
Q2 2025

A detailed history of Rafferty Asset Management, LLC transactions in Novavax Inc stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 254,014 shares of NVAX stock, worth $2.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

254,014

Previous 277,715 8.53%

Holding current value

$2.23 Million

Previous $1.78 Million 10.11%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$5.43 - $7.74 $128,696 - $183,445	-23,701 Reduced 8.53%	254,014 $1.6 Million
Q1 2025 May 14, 2025	SELL	$6.41 - $10.82 $516,017 - $871,031	-80,502 Reduced 22.47%	277,715 $1.78 Million
Q4 2024 Feb 14, 2025	SELL	$7.22 - $14.68 $124,378 - $252,892	-17,227 Reduced 4.59%	358,217 $2.88 Million
Q3 2024 Nov 13, 2024	BUY	$10.71 - $17.11 $1.22 Million - $1.94 Million	113,572 Added 43.37%	375,444 $4.74 Million
Q2 2024 Aug 13, 2024	SELL	$3.89 - $20.97 $5.53 Million - $29.8 Million	-1,420,787 Reduced 84.44%	261,872 $3.32 Million
Q1 2024 May 13, 2024	BUY	$3.76 - $6.02 $266,279 - $426,330	70,819 Added 4.39%	1,682,659 $8.04 Million
Q4 2023 Feb 13, 2024	BUY	$4.8 - $7.67 $2.97 Million - $4.75 Million	619,370 Added 62.41%	1,611,840 $7.74 Million
Q3 2023 Nov 13, 2023	SELL	$6.81 - $9.74 $814,496 - $1.16 Million	-119,603 Reduced 10.75%	992,470 $7.19 Million
Q2 2023 Aug 11, 2023	BUY	$6.67 - $9.52 $458,869 - $654,937	68,796 Added 6.59%	1,112,073 $8.26 Million
Q1 2023 May 11, 2023	BUY	$5.76 - $12.48 $3.2 Million - $6.92 Million	554,753 Added 113.56%	1,043,277 $7.23 Million
Q4 2022 Feb 13, 2023	BUY	$8.86 - $25.04 $2.39 Million - $6.76 Million	270,106 Added 123.66%	488,524 $5.02 Million
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $2.26 Million - $9.47 Million	124,401 Added 132.32%	218,418 $3.98 Million
Q2 2022 Aug 12, 2022	BUY	$36.28 - $75.29 $753,027 - $1.56 Million	20,756 Added 28.33%	94,017 $4.84 Million
Q1 2022 May 13, 2022	BUY	$69.73 - $142.9 $2.9 Million - $5.94 Million	41,601 Added 131.4%	73,261 $5.4 Million
Q4 2021 Feb 10, 2022	BUY	$134.56 - $217.97 $2.53 Million - $4.1 Million	18,796 Added 146.11%	31,660 $4.53 Million
Q3 2021 Nov 10, 2021	BUY	$177.8 - $270.58 $75,565 - $114,996	425 Added 3.42%	12,864 $2.67 Million
Q2 2021 Aug 10, 2021	SELL	$121.0 - $257.67 $484,847 - $1.03 Million	-4,007 Reduced 24.36%	12,439 $2.64 Million
Q1 2021 May 10, 2021	BUY	$112.98 - $319.93 $1.01 Million - $2.87 Million	8,981 Added 120.31%	16,446 $2.98 Million
Q4 2020 Feb 10, 2021	SELL	$78.74 - $139.5 $1.05 Million - $1.86 Million	-13,323 Reduced 64.09%	7,465 $832,000
Q3 2020 Nov 13, 2020	SELL	$79.44 - $178.51 $13,504 - $30,346	-170 Reduced 0.81%	20,788 $2.25 Million
Q2 2020 Aug 07, 2020	BUY	$13.86 - $83.61 $290,477 - $1.75 Million	20,958 New	20,958 $1.75 Million

Others Institutions Holding NVAX

# of Institutions

309

Shares Held

94.3M

Call Options Held

6.11M

Put Options Held

10.7M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $688M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Novavax Inc Transaction History